ABHD17AP3

Across TCGA pan-cancer cohorts, ABHD17AP3 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated ABHD17AP3 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher ABHD17AP3 RNA is associated with better overall survival. In most high-consensus cancer types, elevated ABHD17AP3 expression acts as an unfavorable survival marker, although some lineages such as SKCM and THYM show a favorable association.

SKCM, ACC, and LGG are the cancer types where ABHD17AP3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Quartile	III,IV	0.581	0.258	<.001	53	view →
ACC	DFS	Tertile	All	0.294	0.719	<.001	41	view →
LGG	DFS	Median	All	0.668	0.800	<.001	40	view →
THYM	OS	Median	All	0.965	0.647	.002	37	view →
UCEC	DFS	Tertile	IV	0.731	0.217	.005	24	view →
KIRC	DFS	Quartile	IV	0.211	0.682	.012	14	view →
THCA	DFS	Tertile	IV	0.747	1.000	.008	14	view →
LIHC	OS	Median	III,IV	0.338	0.677	<.001	14	view →
DLBC	DFS	Median	All	0.603	0.921	.005	13	view →
KIRP	DFS	Median	All	0.471	0.696	.010	13	view →
OV	DFS	Tertile	III,IV	0.325	0.418	.014	12	view →
CESC	DFS	Quartile	III,IV	0.830	0.238	.007	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

ABHD17AP3–SKCM (OS)

Open the SKCM breakdown →